Panel: Pharma Manufacturing in Emerging Markets - Towards Localisation in Africa?

Panel: Pharma Manufacturing in Emerging Markets - Towards Localisation in Africa?

Tuesday, October 8, 2024 4:15 PM to 5:00 PM · 45 min. (Europe/Madrid)
Hall 5 - 5B49
Manufacturing 5.0
Regional Insights

Information

Africa stands at the cusp of unprecedented growth, offering a wealth of opportunities for strategic partnerships and investment.  Unprecedented momentum in catalytic initiatives for ecosystem development offer potential for unlocking aggregate commercial opportunity greater than $20Bn.  By fostering collaborations between global health actors, local institutions, investors, and international companies, Africa can harness its vast potential. Join us as we explore opportunities that Africa can offer to the Global Pharma Industry  _x000D_ _x000D_ _x000D_ Establishing strategic partnerships between local institutes, investors and international companies  _x000D_ _x000D_ _x000D_ Initiatives around regulatory capacity, local infrastructure and value chain to help attract foreign investment

Thermo Fisher Scientific7B18Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics, and commercial manufacturing through our Patheon brand. We partner with customers in the pharmaceutical, biotech, and life science industries as their trusted CDMO to deliver medicine to patients faster. We believe that doing this successfully not only requires science, technology, and world-class expertise, but also requires a strategic partnership - bonded by key elements such as trust, communication and collaboration. We embed these elements into every operation, interaction, and step in the drug development journey. With more than 60 locations around the world, we are committed to providing Accelerator(TM) Drug Development, 360˚ CDMO and CRO solutions, to support our customers' aspirations to get treatments to patients, faster. Our pharma services include API, biologics, cell therapy, viral vectors, formulation, clinical trials solutions, logistics services, commercial manufacturing, and packaging. We couple our scientific and technical excellence in all areas with a strategic partnership, to provide customers of all sizes access to a global network of facilities and dedicated experts across the Americas, Europe, Asia, and Australia. At Thermo Fisher Scientific, we understand that developing novel therapies and moving them from discovery to patients is a complex, high-risk process. Every customer has different needs, and every newly discovered drug has a unique pathway to reach the market. As a global, full-service CDMO and CRO partner, we help our partners bring innovative molecules and life-changing therapies to market as efficiently and safely as possible.

Registered attendees

Ademola Osigbesan
Ademola Osigbesan
Sourcing Lead, Access and Regional ManufacturingUnitaid
Angela Vollstedt
Angela Vollstedt
Global Director, Cell & Gene Therapies Portfolio ManagementNovartis
Bernardo Estupiñán Gaisbauer
Bernardo Estupiñán Gaisbauer
Managing PartnerCDMO Advisor

Log in